Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kazakhstan
Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 49.0% in 2025. ◆ Volatile
Latest (2025)
49.0%
Change on year
up 11.4%
World rank
156th
of 194 countries
All-time high
86.0%
in 2016
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kazakhstan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Kazakhstan recorded 49.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 11.4% on the previous year and down 27.9% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Kazakhstan peaked at 86.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Kazakhstan 156th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kazakhstan, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 37.0% | — |
| 2013 | 52.0% | +40.5% |
| 2014 | 58.0% | +11.5% |
| 2015 | 68.0% | +17.2% |
| 2016 | 86.0% | +26.5% |
| 2017 | 81.0% | -5.8% |
| 2018 | 72.0% | -11.1% |
| 2019 | 60.0% | -16.7% |
| 2020 | 55.0% | -8.3% |
| 2021 | 53.0% | -3.6% |
| 2022 | 52.0% | -1.9% |
| 2023 | 52.0% | +0.0% |
| 2024 | 44.0% | -15.4% |
| 2025 | 49.0% | +11.4% |
Kazakhstan compared with similar countries
- Kazakhstan's 49.0% is below the median for upper middle income countries, which is 76.0%, 64% of the median. (57 countries reporting)
- Kazakhstan's 49.0% is below the median for Europe & Central Asia, which is 87.0%, 56% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 51.4% | 0.0% | 86.0% | 10 |
| 2020s | 50.8% | 44.0% | 55.0% | 6 |
Countries ranked near Kazakhstan
- 153 Angola 54.0% compare
- 153 Iran 54.0% compare
- 155 Azerbaijan 52.0% compare
- 156 Chad 49.0% compare
- 158 Central African Republic 45.0% compare
- 159 Papua New Guinea 44.0% compare
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Kazakhstan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Kazakhstan was 49.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kazakhstan?
- The highest recorded value was 86.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kazakhstan?
- The lowest recorded value was 0.0% in 2008.
- How does Kazakhstan rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Kazakhstan ranks 156th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Kazakhstan?
- Over the last ten years it is down 27.9%. The long-run trend across the full record is volatile.
- Where does this Kazakhstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).